Product Information
POTASSIUM CL ER 20 MEQ TABLET is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.1859 per EA under NDC 70436015301. Its NADAC has been published 330 times since Jun 10, 2020.
FDA first approved this application on Sep 30, 2019. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1500 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436015301
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212561FDA Approved
9/30/2019
TE Code
AB3
On Market Since
2/1/2020
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CL ER 20 MEQ TABLET has been published 330 times since Jun 10, 2020, and over the history we have for it it has declined 31.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1859 per EA |
|---|---|
| All-time high | $0.3230 (Feb 16, 2022) |
| All-time low | $0.1290 (Nov 20, 2024) |
| 52-week high | $0.1859 |
| 52-week low | $0.1593 |
| Median price | $0.2743 |
| Average price | $0.2440 |
| Largest weekly change | +66.3% (Aug 21, 2024) |
| Weeks tracked | 330 |
| Tracking since | Jun 10, 2020 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Slate Run Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Potassium Chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CL ER 20 MEQ TABLET?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 20 MEQ TABLET, manufactured by Slate Run Pharmaceuticals LLC, is $0.1859 per EA (NDC 70436015301), effective Sep 30, 2026.
How has the price of POTASSIUM CL ER 20 MEQ TABLET changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL ER 20 MEQ TABLET has declined 31.2%. It has been tracked across 330 weekly CMS publications since Jun 10, 2020.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 20 MEQ TABLET?
Since Jun 10, 2020, the NADAC for POTASSIUM CL ER 20 MEQ TABLET has ranged from a low of $0.1290 (Nov 20, 2024) to a high of $0.3230 (Feb 16, 2022), with a median of $0.2743 per EA.
Are there cheaper alternatives to POTASSIUM CL ER 20 MEQ TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 20 MEQ TABLET, is $0.1408 per EA — about 24% below POTASSIUM CL ER 20 MEQ TABLET.
Who manufactures POTASSIUM CL ER 20 MEQ TABLET?
POTASSIUM CL ER 20 MEQ TABLET (NDC 70436015301) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.